csirt@kutim:~/threat-intel/cve/CVE-2022-35942

Katalog CVE

CVSS 10.0 · Critical EPSS 0,64%

Kerentanan Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') pada linuxfoundation loopback-connector-postgresql. Skor CVSS 3.1 10.0 (Critical) menurut NVD.

Deskripsi (NVD)

Improper input validation on the `contains` LoopBack filter may allow for arbitrary SQL injection. When the extended filter property `contains` is permitted to be interpreted by the Postgres connector, it is possible to inject arbitrary SQL which may affect the confidentiality and integrity of data stored on the connected database. A patch was released in version 5.5.1. This affects users who does any of the following: - Connect to the database via the DataSource with `allowExtendedProperties: true` setting OR - Uses the connector's CRUD methods directly OR - Uses the connector's other methods to interpret the LoopBack filter. Users who are unable to upgrade should do the following if applicable: - Remove `allowExtendedProperties: true` DataSource setting - Add `allowExtendedProperties: false` DataSource setting - When passing directly to the connector functions, manually sanitize the user input for the `contains` LoopBack filter beforehand.

Rincian

Terbit di NVD
12 Agustus 2022
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
10.0 (Critical), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-89: Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection')
EPSS (30 hari)
0,64% peluang dieksploitasi; lebih tinggi dari 49,1% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
linuxfoundation loopback-connector-postgresql Semua versi sebelum 5.5.1

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.